UK markets close in 6 hours 43 minutes

  • FTSE 100

    6,683.17
    -32.25 (-0.48%)
     

  • FTSE 250

    20,672.25
    -121.47 (-0.58%)
     

  • AIM

    1,193.15
    -4.94 (-0.41%)
     

  • GBP/EUR

    1.1224
    -0.0057 (-0.50%)
     

  • GBP/USD

    1.3652
    -0.0078 (-0.57%)
     

  • BTC-GBP

    23,075.36
    +870.82 (+3.92%)
     

  • CMC Crypto 200

    623.04
    +13.05 (+2.14%)
     

  • S&P 500

    3,853.07
    +1.22 (+0.03%)
     

  • DOW

    31,176.01
    -12.37 (-0.04%)
     

  • CRUDE OIL

    52.31
    -0.82 (-1.54%)
     

  • GOLD FUTURES

    1,860.60
    -5.30 (-0.28%)
     

  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     

  • HANG SENG

    29,447.85
    -479.91 (-1.60%)
     

  • DAX

    13,789.35
    -117.32 (-0.84%)
     

  • CAC 40

    5,534.73
    -56.06 (-1.00%)
     
Pharma:

US drug authority approves world's first long-acting HIV regimen

Cabenuva's injectable HIV treatment regimen — which is administered once a month — does not require daily pills

UK government to extend dormant asset funds beyond banks

Suban Abdulla
·2-min read
Pound coins and bank notes.
UK account holders have only reclaimed £93m in total since the Reclaim Fund was established. Photo: Getty

UK savers who lost track of their pension and investment funds will have their money used for charitable causes under new government plans to expand its dormant asset scheme beyond banks.

The move will see more than £800m ($1bn) made available to charities to support unemployed young people, those in financial difficulty, and the UK’s growing social investment market.

The Reclaim Fund was established in 2011 after banks were accused of boosting their balance sheets by sitting on dormant savings.

Currently, around 30 banks and building societies take part in the scheme, but the new scheme will open to City firms across the pensions, insurance, investment and wealth management sectors. Each sector will have their own rules to decide when assets should be shifted to the Reclaim Fund.

Under the current scheme, cash is distributed from bank and building society accounts that are left unclaimed for at least 15 years.

Firms are expected to trace down account holders and reunite them with their savings before the dormant cash is handed over to the government’s Reclaim Fund.

But, only a small proportion of deposits are ever recovered by their rightful owners after they are transferred, at a rate of just 5% a year.

In May, the government released £150m from the Reclaim Fund to charities to help provide COVID-19 relief to social enterprises and vulnerable individuals.

READ MORE: Job losses, GDP collapse, and soaring debt: How COVID-19 ravaged the UK economy

The government has to put forward legislation to expand the fund before it can move forward with the proposed changes.

The programme distributes half of the assets to good causes, while retaining half to reimburse anyone who does eventually come forward to claim the money.

So far, it has distributed £745m to charitable causes, against “just £200m initially expected.” Diana Barran, the minister for civil society, said. “That’s a pretty good experience to build on.”

Since the fund was established, account holders have only reclaimed £93m in total. This is less than 7% of the £1.35bn collected by the scheme over the same period and lower than the £147m transferred in 2019.

The Department for Digital, Culture, Media and Sport said that customers would still be able to apply to reclaim their assets in full at any time. It added that the expanded scheme “will have consumer protection at its heart, with the priority continuing to be locating and reuniting people with their financial assets.”

Watch: Why can't governments just print more money?

Latest stories

  • Sir Billy Connolly has had his coronavirus jab

    The Scottish comedian’s wife Pamela Stephenson revealed in a post on social media that he had received his first jab.

  • Piers Morgan reveals Trump fell victim to hoax caller who impersonated him

    Trump apparently believed he was talking to the real Piers Morgan.

  • BH Global Limited - Investment Management Agreement

    BH Global Limited (the "Company") (a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 48555)

  • The global transient protein expression market is expected to reach US$ 983.10 million by 2027 from US$ 660.00 million in 2019

    The market is estimated to grow at a CAGR of 5. 3% from 2020 to 2027. Increasing applications of protein expression and growing adoption of precision medicines are expected to boost the market growth over the years.New York, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transient Protein Expression Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type ; Application ; End User, and Geography." - https://www.reportlinker.com/p06010110/?utm_source=GNW However, high cost of products are likely to pose a negative impact on the market growth.Transient protein expression procedure has been widely in use for animal and plant cells for the last three decades.However, in the recent years, significant evolution in proteomics has resulted in the development of recombinant proteins.The effective results of transient protein expression in animals and plants have increased research and product development for human applications.Various companies, including biopharmaceuticals and contract research and development organizations have channelized their efforts toward the development of products based on transient protein expression.The adoption of transient protein expression allow companies to get various genes to develop recombinant proteins without delaying cell line generation.Thus, the quick process of cell line development with required gene expression, companies are widely attracted towards uniform proteins that have drug-like properties, which allows production of vaccines and viral vectors. In addition, the transient protein expression process is widely being used in the production of monoclonal antibodies, modified human proteins, growth factors and cytokines, hormones, and blood products.The COVID–19 pandemic has resulted in rise in the use of transient protein expression in vaccine development.Various researchers have started studying the novel coronavirus extensively, with the use of transient protein expression.For instance, in March–April 2020, Absolute Antibody (UK) increased the production of multigram quantities of multiple anti-SARS-CoV-2 spike proteins to develop neutralizing antibodies. Similarly, the transient protein expression was widely used to produce a positive control protein in the development of in-vitro diagnostics kits.Product Type InsightsThe transient protein expression market by product type is segmented into instruments, reagents, vectors, and competent cells.In 2019, instruments segment held a largest market share in the transient protein expression market, by product type.This segment is also expected to dominate the market in 2027 as they are the reducing human input is that it enables continuous cell maintenance and protein production. Moreover, the similar segment is anticipated to also witness the fastest growth rate during the forecast period.Application InsightsBased on application, the global transient protein expression market is segmented into genomic research, gene therapy, bio production, cancer research, and drug development.In 2019, the genomic research segment held the largest market share in the transient protein expression market.This segment is also expected to dominate the market by 2027 as it increases DNA sequencing performance. Moreover, transient protein expression has helped in the study of all the genes of a person (the genome), including their interactions with each other as well as the environment.End User InsightsIn terms of end user, the global transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations.In 2019, the pharmaceutical and biotechnology companies segment held the largest market share.This segment is also expected to dominate the market during the forecast period as pharmaceutical and biotechnology firms are increasing their spending on research and R&D activities. Moreover, transient protein expression has helped the recent improvements in existing technologies and it is moving toward industrial production of plant-based vaccines, antibodies, and biopharmaceuticals.Major primary and secondary sources for transient protein expression included in the report are National Research Council Canada, UK BioIndustry Association, Australian Cluster Observatory and McKell Institute, UAE Federal Customs Authority, and Alpen Capital’s report, among others.Read the full report: https://www.reportlinker.com/p06010110/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Outlook on the Direct to Consumer Testing Global Industry to 2025

    Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Direct to Consumer Testing Industry: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive analysis of the DTC testing market in a global context, including market forecasts and sales through 2025. The report analyzes the market by segmenting it into the different test categories: health and wellness tests, ancestry tests, genetic health risk tests, pharmacogenetics tests, carrier screening tests, overall tests, and others. This study segments the DTC testing market by distribution channel into online, retail, and diagnostic labs. The market is also assessed in all of the geographic regions, including North America, Europe, and emerging markets. The emerging markets include countries and regions like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, and Latin America. The report features new product developments and patents boosting the growth of this market in the global context. This report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on the changing market trends, market players, and their leading products. This chapter also covers the mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that is expected to shape the industry. The factors such as strengths, weaknesses, threats, and opportunities that are expected to play a role in the DTC testing market are evaluated in detail. The report excludes at-home pregnancy and fertility tests. COVID-19 tests are covered, but not their sales. Provider-dependent at-home tests are not included in this report. The Report Includes: 29 data tables and 40 additional tablesAn overview of the global market for Direct-to-consumer (DTC) testing, and discussion on its technology backgroundEstimation of the market size and analyses of global market trends, with data from 2018, 2019, estimates for 2020, with projections of compound annual growth rates (CAGRs) through 2025Comparative study on traditional vs. DTC testing and identification of new opportunities, challenges, and technological changes within the industryMarket share analysis of DTC testing based on type, applications, and distribution channel and evaluation of market size, market forecast, and regulatory landscape of DTC testing industryImpact analysis of COVID-19 on Direct-to-consumer (DTC) testing industryCoverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and details of the investments and new product launches in the marketComprehensive company profiles of market-leading participants, including 23andMe, EasyDNA, Ancestry, Color Genomics, Full Genomes, and Genesis HealthCare Traditionally, diagnostic tests are prescribed by medical practitioners, approved by healthcare providers, and the results are discussed with the patients. The direct-to-consumer (DTC) or at-home tests have transformed conventional testing and have enabled consumers to order their tests from the convenience of their homes, at any time. With no physician approval required, the DTC tests provide the consumers with the freedom to order any test at an affordable cost. Moreover, they have access to the test results, which they can then share with their physicians if they wish to. There are several DTC companies across the globe that offer various types of personalized testing. While the majority of these tests are genetic tests, routine biomarker tests and novel microbiome tests have also entered this booming market. The applications of DTC tests range from ancestry and genealogy testing to screening for diseases in couples, to identification of genes associated with certain heritable diseases and cancers. Advances in genotyping custom arrays have enabled the identification of traits that are linked to fitness, allergies, sleep disorders, neurological diseases, and many other health and wellness aspects. Next-generation sequencing (NGS) techniques and reducing costs of genetic sequencing have led to significant adoption of whole-genome sequencing (WGS) for routine testing. Companies such as Veritas and Nebula Genomics now offer DTC WGS products. Leading players, such as 23andMe, are strategizing new business models to foster growth in this market. Partnerships with healthcare and pharmaceutical companies to drive research in disease pathogenesis and drug discovery are accelerating. Also, many companies have partnered with large healthcare networks such as PWN Health to provide in-house licensed physicians, and thereby, add reliability to their products. The DTC testing market is driven by increasing consumer demand for at-home testing kits, expanding access to these products through online and retail options, decreasing test costs, and expanding applications of these tests. The market is, however, restrained by a lack of proper regulation for DTC tests. Data privacy and security are ongoing challenges. Lack of population-specific databases has also delayed the adoption of tests by many populations. As new players enter the emerging markets and population-based projects also expand, the DTC testing market is expected to have new opportunities in these regions. Growing consumer awareness and improving lifestyles are also expected to contribute to the further growth of this market. Many players, including Quest Diagnostics, EverlyWell, and many others, launched COVID-19 at-home testing kits. Sales from these kits are expected to boost the market growth in the coming years. Key Topics Covered: Chapter 1 Introduction Study Goals and ObjectivesReasons for Doing This StudyScope of ReportInformation SourcesMethodologyGeographic BreakdownAnalyst's CredentialsCustom ResearchRelated Reports Chapter 2 Summary and Highlights Key Highlights Chapter 3 Market and Technology Background History of DTC TestingDifference between Traditional and DTC TestingTypes of DTC TestsGenetic TestsBiomarker-based TestsMicrobiome TestsPopulation Databases or BiobanksApplications of DTC TestingHealth and WellnessAncestry and Genealogy TestingCarrier ScreeningDisease Risk AssessmentPharmacogeneticsWhole Genome SequencingOthersRegulatory Landscape of the DTC Testing IndustryRole of Federal Agencies in the DTC Testing IndustryData Privacy and Security Chapter 4 Market Breakdown by Technology Type of Test COVID-19 and DTC TestingAt-Home COVID-19 Test ProcessAt-Home COVID-19 TestsGlobal Market for DTC Tests by TypeMarket OverviewMarket RevenueMarket SharesDTC Genetic TestingDTC Biomarker-Based TestingDTC Microbiome Testing Chapter 5 Market Breakdown by Distribution Channel Global Market for DTC Tests by Distribution ChannelMarket OverviewMarket RevenueMarket SharesOnline ChannelRetail Channel Chapter 6 Market Breakdown by Application Global Market for DTC Testing by ApplicationMarket OverviewMarket RevenueMarket SharesHealth and Wellness TestingAncestry and Genealogy TestsDisease Risk AssessmentCarrier ScreeningPharmacogenetic TestingWhole Genome Sequence-based DTC TestingOther DTC Tests Chapter 7 Industry Structure Business Models in DTC TestingTraditional Business Model of DTC TestingEmerging Business Models of DTC TestingGrants and Funding in the DTC Testing IndustryCollaborations and PartnershipsMergers and AcquisitionsLeading Market Players in the DTC Testing IndustryLeading Market Players in Genetic DTC Tests MarketLeading Players in the Market for Biomarker-based DTC TestsLeading Players in the Market for DTC Microbiome Tests Chapter 8 Patent Review/ New Developments Patent AnalysisPatents by YearPatents by TypePatents by CompanyPatents by CountryPatents by Assignee Chapter 9 Analysis of Market Opportunities Strengths of the Global DTC Testing MarketIncreasing Consumer AwarenessDecreasing Costs of Genetic SequencingImprovized Business Models and MarketingChallenges within the Global DTC Testing MarketLack of Regulatory GuidanceFalse PositivesSaturation in Product OfferingsEthical and Data Privacy IssuesOpportunities within the Global DTC Testing MarketEmerging MarketsPharma Tie-upsGrowing Number of ApplicationsCovid-19 PandemicThreats within the Global DTC Testing MarketCompetitionRegulatory Constraints Chapter 10 Company Profiles 23AndmeAncestry.Com LlcChengdu Twenty-Three Rubik Cube Biotechnology Co. Ltd. (23Mofang)Circle DNA (Prenetics Ltd.)Color Genomics Inc.Dante LabsEasydnaEverlywell Inc.Fitness Genes Ltd.Full Genomes Corp.Helix Opco LlcIdentigene Llc (Acquired By DNA Diagnostics Center)Karmagenes SaLaboratory Corp. Of America HoldingsLetsgetchecked (Privapath Diagnostics Ltd.)Living DNA Ltd.Mapymygenome India Ltd.MyHeritage Ltd.Microbiome Labs LlcNebula Genomics, Inc.Omecare (Formerly Known As Pathway Genomics)Psomagen Inc.Quest DirectThryve (Quantbiome Inc.)Veritas Genetics International Ltd.Viome Inc. Chapter 11 Appendix: Acronyms For more information about this report visit https://www.researchandmarkets.com/r/4z82uc CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Coronavirus news - live: £500 could be paid to people with Covid as UK considers closing borders

    Follow for the latest updates

  • Global Xanthates Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

    The "Xanthates - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

  • Nurse who breached SHN to help pregnant friend with wedding preparations jailed

    A nurse breached her SHN to buy bubble tea, file an application for further studies, and help a pregnant friend with her wedding preparations.

  • Charging Network EVgo Near Merger With Climate Change SPAC

    (Bloomberg) -- EVgo Services LLC, a charging network for electric vehicles that’s entirely powered by renewable energy, is nearing a deal to go public through a merger with Climate Change Crisis Real Impact I Acquisition Corp., according to people with knowledge of the matter.A transaction is set to value the combined entity at more than $2 billion, said one of the people, who asked not to be identified as the information is private. An announcement could come as soon as Friday, the people said.Shares of Climate Change Crisis, which is a special purpose acquisition company, jumped as much as 117% in pre-market trading Friday. They were up 65% to $22 at 4:36 a.m. in New York.As with any deal that isn’t yet finalized, it could still be delayed or talks could collapse. A representative for EVgo didn’t immediately respond to a request for comment, and a spokesman for the Climate Change Crisis SPAC declined to comment.Read more: An EV Charging Station CEO Plans to Electrify the RoadsEVgo, founded in 2010, has more than 800 fast charging locations in over 600 cities across 34 U.S. states, serving a customer base in excess of 200,000, its website shows. Its partners include automakers like BMW AG, General Motors Co., Nissan Motor Co. and rideshare operators such as Uber Technologies Inc.The SPAC, led by Chief Executive Officer David Crane and Chief Financial Officer John Cavalier, in September raised $230 million to pursue a target in the climate sector.Another electric vehicle charging specialist, EVBox, in December agreed to go public through a merger with blank-check firm TPG Pace Beneficial Finance Corp., which has seen its shares more than double since that announcement.Read more: Biden’s Charging Plan Could Sell 25 Million EVs(Updates with share reaction in third paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • McGregor vs Poirier weigh-in - LIVE: Stream, how to watch online and latest updates

    The Notorious is looking to kick-start what he hopes to be a new reign at the top of the UFC with Khabib Nurmagomedov retired for now

  • Coronavirus: Britain ramps up flight ban as Portugal suspends all UK travel

    Britain is banning all arrivals from Tanzania and Democratic Republic of Congo from Friday, transport secretary Grant Shapps tweeted.

  • $1.3 Billion Worldwide Diacetone Alcohol Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

    The "Diacetone Alcohol - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

  • Opportunities and Risks in the Mexico Cards and Payments Market to 2024 - ResearchAndMarkets.com

    The "Mexico Cards and Payments - Opportunities and Risks to 2024" report has been added to ResearchAndMarkets.com's offering.

  • This clever item will stop your washing machine from shaking

    It's a top rated buy on Amazon, with a huge amount of 5-star reviews.

  • WandaVision episode 3 review: "Feeling more like a product of the Marvel Cinematic Universe"

    Warning: This WandaVision episode 3 review contains spoilers. If you have not watched the Disney Plus show yet, then bookmark this page and come back when you're all caught up... Mirroring this, the episode centres on Wanda’s new pregnancy, which is rapidly progressing – to very funny results.

  • UK lockdown sends economy spiralling at sharpest rate since last May

    The third national lockdown hammered the economy, according to a poll, with a double-dip recession now expected by analysts.

  • From Oil to Energy: IOC Strategies for the Energy Transition - Fastest Growth Expected in Solar and Offshore Wind (2020 Research Report)

    Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "From Oil to Energy - IOC Strategies for the Energy Transition" report has been added to ResearchAndMarkets.com's offering. Oil and gas demand hit hard by COVID-19 shock. Potential for long-term behavioral change after lockdown experiences creates uncertainty over transportation demand for oil. Majority of future power demand growth to be supplied by renewables. Major IOCs recognized large impairments in Q2 after downward revisions to future oil and gas price assumptions.Scope IOC targets for the energy transitionIOCs investments in multiple transition technologiesBP Transition TargetsHow wider oil and gas sector preparing for transition Reasons to Buy Understand the factors supporting the energy transition among IOCsIdentify net zero ambitions of major European IOCsUnderstand key technologies IOCs are investing for for energy transition.Analyze BP's energy transition strategy Key Topics Covered: Questions over recovery of oil and gas demand from COVID 19 shockIOC targets for the energy transitionEuropean majors leading the charge on renewablesFastest growth expected in solar and offshore windIOCs pursuing investments in multiple transition technologiesBP Focus: Key targets for transformation to an Integrated Energy CompanyBP Focus: Future Investment OutlookBP Focus: Downsizing of traditional hydrocarbons businessBP Focus: Low carbon M&ABP Focus: Prospects for key growth segmentsWider oil and gas Challenges and opportunities for the wider market For more information about this report visit https://www.researchandmarkets.com/r/ugq95g Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Chrissy Teigen Shared A Moving Post About Her Newfound Sobriety

    'everything is new and better,' Teigen wrote

  • The best movies to stream this weekend: 'The White Tiger', 'Booksmart' and more

    Judd Apatow's latest comedy lands on Sky Cinema this weekend, where it will compete for attention with Olivia Wilde's directorial debut and a new Netflix film.

  • Hackney Council asks postal voters to submit new applications after cyber attack

    The east London authority was targeted by cyber criminals in October.